AngioDynamics CEO Touts Debt-Free Turnaround, Auryon Share Gains, NanoKnife Launch at Needham Conf

CEO Jim Clemmer used a presentation at Needham & Company’s 25th Annual Needham Healthcare Conference to outline the company’s ...
Business Wire

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Nasdaq

AngioDynamics Receives FDA 510(k) Clearance For Auryon XL Catheter

(RTTNews) - AngioDynamics, Inc. (ANGO) announced on Tuesday that it has received FDA 510(k) clearance for the Auryon XL Catheter, a 225-cm radial access catheter designed for use with the Auryon ...
Seeking Alpha

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee Blockages LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (ANGO), a medical technology company focused ...
Seeking Alpha

AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

Trial Evaluates Effectiveness of Innovative Auryon Atherectomy System in Complex Below-the-Knee Cases LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (ANGO), a leading and transformative medical ...
Hosted on MSN

AngioDynamics targets 14%-16% MedTech growth for fiscal 2025 driven by thrombectomy and NanoKnife adoption

CEO Jim Clemmer highlighted strong Q3 performance with total revenue reaching $72 million, reflecting over 9% year-over-year growth. MedTech revenue grew by 22%, with continued success across ...
Yahoo Finance

AngioDynamics Q3 Earnings Call Highlights

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...